Drug
Imiquimod
Imiquimod: highest development phase Phase 3, developed by Teva. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Teva
Trials
| Drug | Phase | Indication |
|---|---|---|
| Imiquimod Cream, 3.75% NCT01686152 | Phase 3 | Actinic Keratosis |
Latest
No recent events.
Follow Imiquimod on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.